Skip to main content
Premium Trial:

Request an Annual Quote

BGI, TGAC Collaborating on Food Security, Health

NEW YORK (GenomeWeb News) – BGI and The Genome Analysis Center said on Tuesday they will collaborate to "foster key research developments in the areas of food security, energy, and health."

Part of the research being undertaken as part of the partnership is focused on crop genomics. BGI and TGAC already are working on important crop species, including wheat, barley, and rice, and they plan on investigating methods of improving crops and food security by applying sequencing technologies with new computational solutions, such as rapidly identifying alleles associated with desired traits.

They also will investigate ways of deriving energy from crops.

As part of the collaboration, a fellowship program is planned for Chinese researchers who are early in their careers, providing them with access to expertise and educational opportunities at the Norwich Research Park in the UK, where TGAC is based.

"This is a great opportunity to build on our relationship with BGI and form a long-term collaboration with them," TGAC Acting Director Mario Caccamo said in a statement. "The Norwich Research Park has emerged as a leader in plant genomics research and biotechnology. The partnership between TGAC and BGI will facilitate future implementation of novel solutions to tackle important global challenges in food security and sustainable energy."

Ning Li, director of BGI Europe, added, "We would like to collaborate with more researchers in Europe to better accelerate the genomic studies on human health, agriculture, bio-energy, as well as other innovative research."

Financial and other terms of the alliance were not disclosed.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.